Patent: 8,921,414
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 8,921,414
Title: | Spiroketals |
Abstract: | The present invention relates to spiroketal compounds that are useful in methods of treating or preventing protozoal infections, parasitic infections, bacterial infections, cell proliferative disorders and anti inflammatory disorders. The spiroketal compounds are also useful as immunosuppressive agents, and also in methods of controlling pests. |
Inventor(s): | Reddell; Paul Warren (Yungaburra, AU), Gordon; Victoria Anne (Yungaburra, AU) |
Assignee: | EcoBiotics Ltd (Yungaburra, Queensland, AU) |
Application Number: | 14/221,629 |
Patent Claims: | see list of patent claims |
Details for Patent 8,921,414
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | ⤷ Try a Trial | 2025-12-23 |
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | ⤷ Try a Trial | 2025-12-23 |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2025-12-23 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |